rss
Thorax 1990;45:709-710 doi:10.1136/thx.45.9.709
  • Research Article

Pulmonary disease following intravesical BCG treatment.

  1. S Kesten,
  2. L Title,
  3. B Mullen,
  4. R Grossman
  1. Mount Sinai Hospital, Toronto, Canada.

      Abstract

      Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.

      This Article

      1. Abstract
      2. PDF

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
      View free sample issue >>

      Free archive
      The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.